+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study



Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study



European Journal of Cancer Prevention 26 Joining Forces for Better Cancer Registration in Europe: S164-S169



Hodgkin lymphoma (HL) is characterized by heterogeneous histologic findings, clinical presentation and outcomes. Using the Girona population-based cancer registry data we sought to explore the incidence of HL over three decades in Girona Province (Spain) and examine the relationship between clinical features at diagnosis and survival. From 1985 to 2013, 459 cases were recorded. Patients were stratified by sex, age group, stage at diagnosis, histological subtypes and the presence of B-symptoms. The crude incidence rate (CR) was 2.7 and the corresponding European age-adjusted rate was 2.6, being higher in men than in women (sex ratio=1.6). Incidence remained constant throughout the period of study. Nodular sclerosis was the most frequent histology and showed an increasing incidence over time [estimated annual percentage change=+2.4, 95% confidence interval (CI): 0.8-4.0]. The 5-year observed survival and relative survival of patients diagnosed with HL were 73.1% (95% CI: 69.0-77.5) and 74.6% (95% CI: 70.0-79.4), respectively. No statistical differences in observed survival were observed across the three decades of study (P=0.455). Clinical parameters negatively influencing 5-year relative survival in the multivariate analysis were as follows: age at diagnosis at least 65 years; clinical stage IV; and presence of B-symptoms. These current patterns of presentation and outcomes of HL help delineate key populations in order to explore risk factors for HL and strategies to improve treatment outcomes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059847197

Download citation: RISBibTeXText

PMID: 28590273

DOI: 10.1097/CEJ.0000000000000383


Related references

Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007. Leukemia Research 36(10): 1262-1266, 2012

Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study. Clinical & Translational Oncology, 2018

Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study. Cancer Epidemiology 45(): 6-10, 2016

Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994-2003. European Journal of Cancer 44(14): 2058-2073, 2008

Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. European Journal of Cancer 43(1): 144-148, 2006

Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005. Journal of Neuro-Oncology 101(1): 117-123, 2011

Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study. European Journal of Haematology 97(4): 393-398, 2016

Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004). Clinical & Translational Oncology, 2018

Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM). Acta Oncologica 48(7): 977-983, 2010

Neuroendocrine tumors A population-based study of incidence and survival in Girona province, 1994–24. 2011

Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study. Leukemia & Lymphoma 55(7): 1570-1577, 2016

Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004. Cancer Epidemiology 35(6): E49-E54, 2012

Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age: Analysis of a population-based non-Hodgkin lymphoma registry. Cancer 89(12): 2667-2676, December 15, 2000

No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. Plos One 9(3): E92585-E92585, 2014

Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Cancer 117(24): 5538-5547, 2012